<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The frequency of autoantibodies (AAbs) was surveyed in several <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo>, other <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e>, and controls using antigen-specific EIAs for neurofilament heavy subunit, tubulin, glial fibrillary acidic protein, S100 protein, tau, beta-amyloid <z:chebi fb="7" ids="16670">peptide</z:chebi>, myelin basic protein, and <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> <z:chebi fb="0" ids="37396">proteoglycan</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>High frequencies of sera and cerebrospinal fluid tubulin AAbs were found in <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (62% and 69%, respectively), <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson disease</z:e> (27% and 70%), <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo> (54% and 67%), and in sera from multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (50% and 67%), <z:hpo ids='HP_0100653'>optic neuritis</z:hpo> (85%), <z:e sem="disease" ids="C0018378" disease_type="Disease or Syndrome" abbrv="">Guillain-Barré syndrome</z:e> (88%), and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (52%) </plain></SENT>
<SENT sid="2" pm="."><plain>High frequencies of neurofilament heavy subunit AAbs were detected in <z:e sem="disease" ids="C0018378" disease_type="Disease or Syndrome" abbrv="">Guillain-Barré syndrome</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> (88%) and <z:hpo ids='HP_0100653'>optic neuritis</z:hpo> (62%); whereas, some <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (33%) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (44%) patients had glial fibrillary acidic protein AAbs </plain></SENT>
<SENT sid="3" pm="."><plain>Lower frequencies of other AAbs were found in patient groups </plain></SENT>
<SENT sid="4" pm="."><plain>AAb results were also compared to functional assessment of blood-brain barrier integrity in <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The relevance of these AAbs to pathogenesis and/or course of <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> merits further study with particular reference to subgrouping and prognosis </plain></SENT>
</text></document>